CIK 0001390478 · Non-accelerated filer<br>Smaller reporting company
SELLAS Life Sciences Group, Inc.
Sign in to watch- Ticker
- SLS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 6462005278
- Business address
- 7 TIMES SQUARE, SUITE 2503, NEW YORK, NY, 10036
- Former names
- GALENA BIOPHARMA, INC., Galena Biopharma, Inc., RXI PHARMACEUTICALS CORP
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale
- UPLOAD Other SEC-generated Letter
- 8-K Event Material agreement · Agreement ended · New debt or obligation
- DEL AM Other DEL AM
- S-1 Offering Registration Statement
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
- UPLOAD Other SEC-generated Letter
- CORRESP Other Correspondence Between Filers and SEC Staff
- DEFA14A Proxy Proxy Materials
- 10-Q Report Quarterly Report
- S-3 Offering Registration Statement
- 8-K Event Material agreement · Unregistered share sale · Other events
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 8-K Event Shareholder vote results
- 8-K Event Executive or director change
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
Page 21 of 64 · 1,276 filings